Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of posaconazole prophylaxis and antifungal treatment on BAL GM performance in hematology malignancy patients with febrile neutropenia: a real life experience.
Acet-Öztürk NA, Ömer-Topçu D, Vurat Acar K, Aydın-Güçlü Ö, Pınar İE, Demirdöğen E, Görek-Dilektaşlı A, Kazak E, Özkocaman V, Ursavas A, Özkalemkaş F, Ener B, Ali R, Akalın H. Acet-Öztürk NA, et al. Among authors: pinar ie. Eur J Clin Microbiol Infect Dis. 2024 Jan;43(1):33-43. doi: 10.1007/s10096-023-04686-7. Epub 2023 Nov 1. Eur J Clin Microbiol Infect Dis. 2024. PMID: 37910269
A Real-life Turkish Experience of Venetoclax Treatment in High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia.
Gemici A, Ozkalemkas F, Dogu MH, Tekinalp A, Alacacioglu I, Guney T, Ince I, Geduk A, Cagliyan GA, Maral S, Serin I, Gunduz E, Karakus V, Bekoz HS, Eren R, Pinar IE, Gunes AK, Sargın FD, Sevindik OG. Gemici A, et al. Among authors: pinar ie. Clin Lymphoma Myeloma Leuk. 2021 Aug;21(8):e686-e692. doi: 10.1016/j.clml.2021.04.004. Epub 2021 Apr 20. Clin Lymphoma Myeloma Leuk. 2021. PMID: 34059487
The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: a retrospective study.
Baysal M, Gürsoy V, Hunutlu FC, Erkan B, Demirci U, Bas V, Gulsaran SK, Pinar IE, Ersal T, Kirkizlar TA, Atli EI, Kirkizlar HO, Ümit EG, Gürkan H, Ozkocaman V, Ozkalemkas F, Demir AM, Ali R. Baysal M, et al. Among authors: pinar ie. Ann Hematol. 2022 May;101(5):1049-1057. doi: 10.1007/s00277-022-04798-8. Epub 2022 Feb 21. Ann Hematol. 2022. PMID: 35190843
Evaluation of Using Empiric Glycopeptides in Accordance with the IDSA Guidelines in Hematologic Malignancy Patients with Febrile Neutropenia.
Yalçın C, Özkalemkaş F, Özkocaman V, Ersal T, Pınar İE, Orhan B, Candar Ö, Çubukçu S, Koca TG, Akyol MN, Ada NG, Özakın C, Kazak E, Akalın H, Ali R. Yalçın C, et al. Among authors: pinar ie. Mediterr J Hematol Infect Dis. 2022 May 1;14(1):e2022039. doi: 10.4084/MJHID.2022.039. eCollection 2022. Mediterr J Hematol Infect Dis. 2022. PMID: 35615332 Free PMC article.
Impact of revised EORTC/MSGERC 2020 criteria on diagnosis and prognosis of invasive pulmonary aspergillosis in patients with hematological malignancies undergoing bronchoscopy.
Acet-Öztürk NA, Ömer-Topçu D, Vurat-Acar K, Aydın-Güçlü Ö, Pınar İE, Demirdöğen E, Görek-Dilektaşlı A, Kazak E, Özkocaman V, Ursavas A, Akalın H, Özkalemkaş F, Ener B, Ali R. Acet-Öztürk NA, et al. Among authors: pinar ie. J Mycol Med. 2022 Nov;32(4):101304. doi: 10.1016/j.mycmed.2022.101304. Epub 2022 Jun 15. J Mycol Med. 2022. PMID: 35738036
16 results